323 results on '"Maschan, Alexey A."'
Search Results
2. The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study
3. Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E–positive LCH
4. A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopenia
5. Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia
6. Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis
7. Cabozantinib in children with recurrent diffuse gliomas.
8. Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome
9. Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA
10. A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety
11. Additional flow cytometric studies for differential diagnosis between Burkitt lymphoma/leukemia and B-cell precursor acute lymphoblastic leukemia
12. Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuria
13. Successful Treatment of Acquired Thrombotic Thrombocytopenic Purpura With Caplacizumab Combined With Plasma Exchanges and Immune Suppression in 3 Children
14. Flow cytometry for comprehensive assessment of platelet functional activity in response to ADP stimulation
15. Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia
16. Mismatched related vs matched unrelated donors in TCRαβ/CD19-depleted HSCT for primary immunodeficiencies
17. Flow cytometry for comprehensive assessment of platelet functional activity in response to ADP stimulation.
18. Unusual Presentation of SET::NUP214-Associated Concomitant Hematological Neoplasm in a Child—Diagnostic and Treatment Struggle
19. Novel Hemizygous CORO1A Variant Leads to Combined Immunodeficiency with Defective Platelet Calcium Signaling and Cell Mobility
20. Heterogeneity of childhood acute leukemia with mature B-cell immunophenotype
21. Novel hemizygous CORO1A variant leads to combined immunodeficiency with defective platelet calcium signaling and cell mobility
22. Accelerated death of megakaryocytes from Wiskott–Aldrich syndrome patients
23. Recognizing Minor Leukemic Populations with Monocytic Features in Mixed-Phenotype Acute Leukemia by Flow Cell Sorting Followed by Cytogenetic and Molecular Studies: Report of Five Exemplary Cases
24. Molecular Heterogeneity of Pediatric AML with Atypical Promyelocytes Accumulation in Children—A Single Center Experience
25. The long-term efficacy and safety of nilotinib in pediatric patients with CML:a 5-year update of the DIALOG study
26. Rare case of pediatric trilineal mixed-phenotype acute leukemia with t(11;19)(q23.3;p13)/KMT2A::ELL
27. Tcrαβ+/CD19+-Depletion in Hematopoietic Stem Cells Transplantation from Matched Unrelated and Haploidentical Donors in Pediatric Acute Lymphoblastic Leukemia Patients in Complete Remission
28. Allogeneic Donor-Derived Myeloid Antigen Directed CAR-T Cells - for Relapsed/Refractory Acute Myeloid Leukemia in Children after Allogeneic Hematopoietic Stem Cell Transplantation: Report of Three Cases
29. Eltrombopag in Pediatric Patients with Previously Untreated or Refractory/Relapsed Severe Aplastic Anemia: The Phase II Escalate Trial
30. Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia
31. Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy
32. Efficacy and safety of a reduced dose of plerixafor in combination with granulocyte colony‐stimulating factor in healthy haploidentical stem cell donors
33. Bone Marrow Transplantation for Fanconi Anemia Using Fludarabine-Based Conditioning
34. Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1 fusion and responding to entrectinib
35. Single Center Experience With Pediatric Patients With GATA2 Deficiency
36. Isatuximab monotherapy in patients with refractory T‐acute lymphoblastic leukemia or T‐lymphoblastic lymphoma: Phase 2 study
37. Pediatric patients with acute lymphoblastic leukemia treated with blinatumomab in a real‐world setting: Results from the NEUF study
38. Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells
39. Acute myeloid leukemia with t(X;6)9p11;q23);MYB-GATA1 and female sex: GATA1 insufficiency may be insufficient for pathogenesis
40. The use of additional immunophenotypic criteria for the differential diagnosis of Burkitt lymphoma/leukemia: An exemplary case report
41. Upfront unrelated donor hematopoietic stem cell transplantation in patients with idiopathic aplastic anemia: A retrospective study of the Severe Aplastic Anemia Working Party of European Bone Marrow Transplantation
42. Healthy pediatric platelets are moderately hyporeactive in comparison with adults’ platelets
43. CD19 CAR-T Cell Therapy in Children with Relapsed and Refractory B-ALL
44. Haploidentical Donor-Derived CAR-T Cells Are Safely and Effectively Co-Infused with the Haploidentical Graft, Depleted of Ab T Cells: Report of Case Series
45. Results of Hematopoietic Stem Cells Transplantation with Tcrαβ and CD19-Depletion from Matched Related Donors and Infusions of CD45RA Depleted Donor Lymphocytes in Pediatric Severe Aplastic Anemia
46. Immune reconstitution following rituximab-based immunochemotherapy in pediatric patients with B-cell non-Hodgkin lymphomas
47. Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome
48. Efficacy and safety of ruxolitinib in ineffective erythropoiesis suppression as a pretransplantation treatment for pediatric patients with beta‐thalassemia major
49. Clinical and Genomic Heterogeneity of Diamond Blackfan Anemia in the Russian Federation
50. A phase 2 study of nilotinib in pediatric patients with CML:Long-term update on growth retardation and safety
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.